NCT07504796 2026-04-21
ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab
NYU Langone Health
Phase 4 Recruiting
Clinical Trials
7 trialsNCT03340506 2026-04-20
Dabrafenib and/or Trametinib Rollover Study
Novartis
Phase 4 Recruiting
NCT07200544 2025-12-15
Meloxicam in Mohs Micrographic Surgery
University of Oklahoma
Phase 4 Recruiting
NCT06499415 2025-05-11
CALM
Maastricht University Medical Center
Phase 4 Recruiting
NCT06627036 2025-01-24
ClearMark
Hull University Teaching Hospitals NHS Trust
Phase 4 Recruiting
NCT06647342 2025-01-23
BLESS
Zealand University Hospital
Phase 4 Recruiting
NCT06116461 2024-04-22
NIVOPTIMIZE
Erasmus Medical Center
Phase 4 Recruiting